
E138: Dapirolizumab for SLE (PHOENYCS-GO)
Jul 24, 2026 - 22:09
Radio and PodcastLive Radio & Podcasts
The Evidence Based Rheumatology Podcast by Michael Putman
Another episode looking into safety this week! Tackling that pesky issue of TNFs and CHF. Be sure to
Continue listening to more episodes from The Evidence Based Rheumatology Podcast.

Jul 24, 2026 - 22:09
A new therapy for SLE! This one is a CD40-CD40L blocker, which has some nice new-things to inhibit. The s...

Jun 29, 2026 - 15:36
Another day, another B cell drug. This one adds an interesting option for IgG4-RD, offering a "maybe less...

Jun 15, 2026 - 13:39
Big trial this week in the NEJM investigating the IL17 inhibitor secukinumab in PMR. Well worth a read, I...

Apr 30, 2026 - 11:03
Really interesting study this week comparing the IL17 inhibitor ixekizumab WITH the GLP1 inhibitor tirzep...

Apr 17, 2026 - 14:58
Great trial this week looking at brepocitinib in dermatomyositis. Looks like a winner, expect it will be...

Mar 19, 2026 - 15:21
Good RCT this week, investigating the CD20 B cell inhibitor obinutuzumab for SLE. Sign up for my newslett...

Mar 5, 2026 - 13:54
Quick podcast this week about a nifty head to head study that I had previously missed. Worth reading if -...

Jan 21, 2026 - 14:48
Today I cover the recent publication of the RESET-RA study, which evaluated vagal nerve stimulation to tr...